Pfizer's Heffner elected NY Pharma Forum president
This article was originally published in Scrip
Executive Summary
The New York Pharma Forum, a non-profit association for international biopharmaceutical corporations, has elected Dr Thomas Heffner president. Dr Heffner is Pfizer's executive director of worldwide business development. In addition, Catherine Sazdanoff, vice-president of business development at Takeda, and Allen Downs, senior executive director of licensing & business development at Purdue Pharma, were elected officers.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.